SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
SHL Telemedicine has officially launched its SmartHeart® membership program in the US, following a successful soft launch in November 2023. This program provides a revolutionary at-home 12-lead ECG service, complete with 24/7 cardiologist reviews and telehealth consultations. The soft launch exceeded expectations, demonstrating substantial demand and positive feedback. Recent clinical studies with Imperial College London showed significant reductions in hospital readmissions and emergency visits among post-ACS patients using SmartHeart®. The membership aims to empower users to manage their heart health proactively with a portable ECG device, expert analysis, and telehealth services.
- Official launch following a highly successful soft launch with substantial demand and positive feedback.
- Significant reductions in hospital readmissions and emergency department visits among post-ACS patients using SmartHeart®, as demonstrated by clinical studies with Imperial College London.
- Portable 12-lead ECG device enables high-quality ECG performance anytime and anywhere.
- 24/7 access to board-certified cardiologists for ECG interpretation.
- On-demand telehealth visits for timely consultations.
- The initiative aims to enhance proactive heart health management.
- The SmartHeart® membership is a private pay program, which may limit accessibility to those who can afford it.
- No specific financial data provided regarding expected revenue or cost projections from the program.
Insights
SmartHeart® membership's launch in the US reflects a significant advancement in the field of telemedicine and remote cardiac care. The service provides 12-lead ECG readings at home, which is a comprehensive way to monitor heart conditions. Typically, ECGs are conducted in clinical settings, requiring visits to healthcare facilities. This development offers considerable convenience for patients, especially those with chronic cardiac conditions, as it reduces the need for frequent hospital visits.
The 24/7 cardiologist interpretation feature is noteworthy. This ensures that patients receive expert analysis promptly, which could lead to quicker interventions when necessary. Additionally, on-demand telehealth visits provide immediate access to medical professionals, enhancing patient care.
The positive results from the clinical study with Imperial College London, which demonstrated a reduction in hospital readmissions and emergency department visits, suggest that SmartHeart® can effectively manage post-acute coronary syndrome (ACS) patients. This is crucial, as reducing readmissions not only benefits patient outcomes but also lessens the financial strain on the healthcare system.
In summary, the SmartHeart® membership offers a potentially transformative approach to managing heart health, especially for patients with chronic conditions and could lead to substantial improvements in healthcare efficiency and patient well-being.
The launch of SmartHeart® membership in the US represents an important move for SHL Telemedicine in capturing a share of the growing telehealth market. The successful soft launch and positive customer feedback suggest a strong market demand, which could translate into significant revenue growth for the company. Given the increasing adoption of telehealth services, especially post-COVID-19, SHL's timing appears strategic.
The membership program is a private pay model, indicating a potential high-margin revenue stream, as it is not reliant on insurance reimbursements. This can be advantageous for SHL's financials by providing a more stable and predictable revenue source. However, the success of this model will depend on consumer willingness to pay out-of-pocket for these services, which could be influenced by the perceived value and effectiveness of the SmartHeart® system.
Additionally, the partnership with Imperial College London and the clinical study results lend credibility to the product, which can enhance consumer trust and adoption rates. This endorsement from a reputable institution can be a powerful marketing tool.
In the long term, if SHL can demonstrate sustained effectiveness and customer satisfaction, it could see increased uptake and potentially expand into other markets. However, competition in the telehealth space is fierce and maintaining technological and service excellence will be key to its success.
A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service now fully available in the US.
This announcement comes after the highly successful soft launch that was announced in November 2023, which exceeded the company's expectations, demonstrating substantial demand and positive customer feedback.
Erez Nachtomy, CEO of SHL Telemedicine commented: "The official launch marks a significant milestone in our mission to transform cardiac care accessibility. The overwhelming success of our soft launch has not only validated the demand for accessible, at-home cardiac care but also underscored the effectiveness of our solutions in enhancing heart health management."
This official launch is further bolstered by the recent, positive results from a clinical study conducted with Imperial College London, which demonstrated significant reductions in hospital readmissions and emergency department visits among post-ACS patients using the SmartHeart® system, underlining its effectiveness and transformative potential in remote cardiac care.
Jason Bottiglieri, General Manager of SHL Telemedicine
The SmartHeart® membership is a private pay program designed to revolutionize home-based access to cardiac care. It includes the innovative, user-friendly SmartHeart® portable 12-lead ECG device, offering round-the-clock interpretation by board-certified cardiologists and on-demand telehealth visits. This initiative not only simplifies the process of conducting a full 12-lead ECG at home but also ensures convenient and dependable heart health management, meeting the evolving needs of today's healthcare consumers.
SmartHeart® Membership Offers:
- Portable 12-lead ECG Device: The SmartHeart® ECG, a cutting-edge and user-friendly device, enables high-quality 12-lead ECG performance anytime and anywhere.
- 24/7 Cardiologist Interpretation: Subscribers have access to expert analysis of their ECG by board-certified cardiologists, offering peace of mind and prompt response to cardiac symptoms.
- On-demand Telehealth Visits: Subscribers can easily access medical professionals for consultations, enabling timely and informed health decisions.
For detailed information on subscription options and availability of the SmartHeart® Membership program in different states, as well as customer testimonials, please visit our website at www.getsmartheart.com.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200).
For more information, please visit our website at www.shl-telemedicine.com.
Forward-Looking Statements
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515833949/en/
Fabienne Farner, IRF, Phone: +41 43 244 81 42, farner@irf-reputation.ch
Source: SHL Telemedicine Ltd.
FAQ
What is the SmartHeart® membership offered by SHL Telemedicine?
When did SHL Telemedicine officially launch the SmartHeart® membership in the US?
What were the results of the clinical study related to SmartHeart®?
What features does the SmartHeart® membership include?
Who can access the SmartHeart® membership?
